Back
PIMCO Corporate & Income Opportunity Fund Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Sell
49
PTY
PIMCO Corporate & Income Opportunity Fund
Last Price:
$13.16
Seasonality Move:
1.69%
Buy
75
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.03
Seasonality Move:
-24.59%
Sell
49
PIMCO Corporate & Income Opportunity Fund (PTY)
is a Sell
Is PIMCO Corporate & Income Opportunity Fund a Buy, Sell or Hold?
-
The current PIMCO Corporate & Income Opportunity Fund [PTY] share price is $13.15. The Score for PTY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $95.99. The Score for DRUG is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTY Stock Price Chart
What is PIMCO Corporate & Income Opportunity Fund's stock price today?
-
The PIMCO Corporate & Income Opportunity Fund share price today is $13.15The current trend is relatively stagnant and PTY is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $95.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 55.72 | Buy |
| Chaikin Money Flow: | -251958 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.86 - 13.14) | Buy |
| Bollinger Bands (100): | (13.15 - 14.31) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.7 | Buy |
| Relative Strength Index (14 RSI): | 65.61 | Buy |
| Chaikin Money Flow: | 292843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.33 - 88.51) | Buy |
| Bollinger Bands (100): | (45.68 - 74.86) | Buy |
PTY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13 | Buy |
| 20-day SMA: | 12.95 | Buy |
| 50-day SMA: | 13.23 | Sell |
| 200-day SMA: | 13.74 | Sell |
| 8-day EMA: | 13.04 | Buy |
| 20-day EMA: | 13.02 | Buy |
| 50-day EMA: | 13.24 | Sell |
| 200-day EMA: | 13.74 | Sell |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.5 | Buy |
| 20-day SMA: | 83.91 | Buy |
| 50-day SMA: | 69.69 | Buy |
| 200-day SMA: | 45.45 | Buy |
| 8-day EMA: | 85.95 | Buy |
| 20-day EMA: | 81.76 | Buy |
| 50-day EMA: | 72.81 | Buy |
| 200-day EMA: | 51.04 | Buy |
PIMCO Corporate & Income Opportunity Fund Earnings Growth & PTY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and a decrease next year of $1.59 per share.
PIMCO Corporate & Income Opportunity Fund Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||